You should be learning to trade nasdaq and nyse stocks more efficiently with age to continually increase your income. Otc, forex and others are too full of misconceptions for me to recommend touching. It's important to understand the difference between risk management vs. riskless management. Risk management implies "how much money are you willing to lose". Whereas riskless management entails making very conservative decisions. When you do well making very conservative decisions, you will see there is simply no rational in taking unnecessary risks. When 25% of your monthly profits becomes enough to cover all your monthly expenses, then you can retire. The reason I say 25% is you must leave most(75%) in your account to ensure strong growth as well as ensure your short term capital gains taxes will always be there at tax time. With this formula the dollar amount of your monthly expense income(25% of your profits) will increase every month for the rest of your life to live very comfortably and take very well care of your family. The principle will have such strong growth that it will make a very good trust fund to help causes inwhich you truly believe in. A directive order in your trust fund to ensure taxes are accounted for should you pass will take the tax liability off of your family. Good luck to all and I hope this formula helps others as it has done for me. Perhaps one day skydiving at 104 years old will become the norm. Until then, bless this wonderful true lady for being an inspiring pioneer at 104.
You have the patience the strength and the passion
To achieve your ambitions your goals and your dreams.
All you need to do is try!
Recent CCCC News
- C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day • GlobeNewswire Inc. • 07/08/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:46:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:45:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 11:41:50 AM
- C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors • GlobeNewswire Inc. • 06/10/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:10:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:07:20 AM
- C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/29/2024 08:01:00 PM
- C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:28:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:26:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:24:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:21:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:19:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:10:39 PM
- C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:05:34 PM
- C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins • GlobeNewswire Inc. • 03/04/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/22/2024 02:01:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 12:20:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:15:04 PM
- C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:07:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM